The CAPTAIN II trial evaluated efficacy and safety in moderate-severe TBI patients, and prospective cohort studies have demonstrated improved functional neurorecovery in clinical populations
GHK-Cu (copper tripeptide Gly-His-Lys) and BPC-157 (Body Protection Compound-157) are two of the most studied research peptides in the context of tissue repair and biological age-related decline
The objective of this review is to provide a comprehensive and structured synthesis of the immunopathogenesis of HT, integrating established knowledge with emerging research areas including oxidative stress, gut microbiota, and epigenetic modifications, while also summarizing current clinical, diagnostic, and therapeutic perspectives (Fig
CagriSema, at least in its current clinical development program, targets a single maintenance dose of 2.4/2.4 mg, offering less room for individualization
Vitamin B12 deficiency may affect between 1.5 to 15 percent of people
A B12 injection is a clinical procedure: site rotation, clean technique and correct dosing matter, which is why a trained clinician is the safest place to have one